REDWOOD CITY, Calif., Feb. 21, 2025 (GLOBE NEWSWIRE) -- Seer, Inc. (NASDAQ:SEER), a leading life sciences company commercializing a disruptive new platform for proteomics, today announced that the company will be participating in the upcoming TD Cowen 45th Annual Healthcare Conference in Boston, MA.Seer's management is scheduled to participate in a fireside chat on Tuesday, March 4th at 11:50 a.m. Eastern Time / 8:50 a.m. Pacific ...Full story available on Benzinga.com